ADAGE CAPITAL PARTNERS GP, L.L.C. – BioMarin Pharmaceutical Inc. Transaction History
ADAGE CAPITAL PARTNERS GP, L.L.C. portfolio value:
$72.05M
portfolio value
ADAGE CAPITAL PARTNERS GP, L.L.C. quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -38.18% | -525K shares | -41.89M | $84.77 | 850K |
Q2 2022 | share | Decrease | -6.78% | -100K shares | 223K | $82.87 | 1.37M |
Q1 2022 | share | Decrease | -20.91% | -390K shares | -51.05M | $77.1 | 1.47M |
Q4 2021 | share | Increase | +372.75% | 1.47M shares | 134.28M | $89.08 | 1.86M |
Q3 2021 | share | Increase | 0.00% | 394.50K shares | 30.49M | $77.29 | 394.50K |
Q4 2020 | share | Decrease | -100.00% | -484K shares | -36.82M | $87.69 | 0 |
Q3 2020 | share | Decrease | -45.86% | -410K shares | -73.44M | $76.08 | 484K |
Q2 2020 | share | Increase | +166.96% | 559.12K shares | 81.96M | $123.34 | 894K |
Q1 2020 | share | Increase | 0.00% | 334.87K shares | 28.29M | $84.5 | 334.87K |
Q2 2019 | share | Decrease | -100.00% | -84K shares | -7.46M | $85.65 | 0 |
Q1 2019 | share | Increase | 0.00% | 84K shares | 7.46M | $88.83 | 84K |
Q3 2017 | share | Decrease | -100.00% | -673K shares | -61.12M | $93.07 | 0 |
Q2 2017 | share | 0.00% | 0 shares | 2.04M | $90.82 | 673K | |
Q1 2017 | share | Increase | +0.45% | 3K shares | 3.57M | $87.78 | 673K |
Q4 2016 | share | Increase | +7.20% | 45K shares | -2.32M | $82.84 | 670K |
Q3 2016 | share | Decrease | -37.50% | -375K shares | -19.97M | $92.52 | 625K |
Q2 2016 | share | Decrease | -5.02% | -52.9K shares | -9.04M | $77.8 | 1M |
Q1 2016 | share | Increase | +316.33% | 800K shares | 60.34M | $82.48 | 1.05M |